Stockreport

Opus Genetics Highlights 2025 Progress and Upcoming 2026 Catalysts

Opus Genetics, Inc.  (IRD) 
PDF - Multi-asset pipeline with significant targeted data readouts and milestones -- Two lead ophthalmic gene therapy programs in clinical trials with new data anticipated i [Read more]